Medasense
Medasense Biometrics Ltd. is a medical device company dedicated to transforming pain assessment and treatment worldwide through innovative AI technology and sensor platforms. Their flagship product, PMD-200™, visualizes pain response to personalize care, and their pipeline products focus on pain prediction, stratification, and prevention strategies. The company collaborates with industry leaders and is committed to improving patient outcomes and reducing healthcare costs by providing objective pain monitoring solutions.
Industries
Nr. of Employees
small (1-50)
Patents
Systems and methods for monitoring physiological parameters during diathermy
US-12076155-B2
View DetailsElectrode array for physiological monitoring and device including or utilizing same
US-11992303-B2
View DetailsElectrode array for physiological monitoring and device including or utilizing same
US-11571137-B2
View Details
Systems and methods for monitoring physiological parameters during diathermy
US-12076155-B2
View DetailsElectrode array for physiological monitoring and device including or utilizing same
US-11992303-B2
View DetailsElectrode array for physiological monitoring and device including or utilizing same
US-11571137-B2
View DetailsProducts
Patient nociception monitoring system (bedside/OR monitor)
A bedside/operating-room patient monitor that integrates non-invasive biosensors and displays a computed nociception index to support intraoperative and critical-care analgesia management.
AI platform for pain prediction and stratification
Algorithmic platform and pipeline that extends real-time nociception monitoring toward pain prediction, patient stratification and prevention strategies.
Patient nociception monitoring system (bedside/OR monitor)
A bedside/operating-room patient monitor that integrates non-invasive biosensors and displays a computed nociception index to support intraoperative and critical-care analgesia management.
AI platform for pain prediction and stratification
Algorithmic platform and pipeline that extends real-time nociception monitoring toward pain prediction, patient stratification and prevention strategies.
Services
Online and customized educational curricula, tutorials and training modules to support clinician competency and product evaluation.
Web-based simulation modules and interactive tools that let clinicians experience and practice use of nociception monitoring in simulated clinical scenarios.
On-site and remote clinical support for product evaluations, including training, reporting, and guidance to integrate monitoring into clinical workflows.
Online and customized educational curricula, tutorials and training modules to support clinician competency and product evaluation.
Web-based simulation modules and interactive tools that let clinicians experience and practice use of nociception monitoring in simulated clinical scenarios.
On-site and remote clinical support for product evaluations, including training, reporting, and guidance to integrate monitoring into clinical workflows.
Expertise Areas
- Nociception and perioperative pain monitoring
- Clinical trial management and evidence generation
- Medical device design and commercialization
- Regulatory compliance and quality systems (medical devices)
Key Technologies
- Machine learning for biosignal analysis
- Multi-parameter physiological signal fusion
- Non-invasive biosensor integration
- Bedside and operating-room patient monitoring hardware
News & Updates
Medasense and Blink Device Company received a grant to develop an advanced anesthesia monitoring system.
Partnership to distribute NOL nociception monitoring technology in Israel.
NOL technology was featured in Nature Outlook highlighting its significance.
Medasense received patent approval for its novel pain-monitoring system.
Medasense and Blink Device Company received a grant to develop an advanced anesthesia monitoring system.
Partnership to distribute NOL nociception monitoring technology in Israel.
NOL technology was featured in Nature Outlook highlighting its significance.
Medasense received patent approval for its novel pain-monitoring system.